Muscular Dystrophy Treatment

How is Muscular Dystrophy Diagnosed?

Muscular dystrophy is usually diagnosed by a neurologist or neuromuscular specialist. The process begins with a detailed medical history, family history and physical examination. The doctor checks for patterns of weakness, difficulty walking, frequent falls, calf enlargement, delayed motor milestones, joint tightness and breathing symptoms.

• Creatine kinase (CK/CPK) blood test: Checks the level of creatine kinase in the blood. A high level, without a recent major injury, may indicate muscle damage and suggest the need for further tests, although it cannot identify the exact type of muscular dystrophy.

• Genetic testing: Helps identify the genetic change responsible for the condition. This is especially important in Duchenne and Becker muscular dystrophy, as the specific mutation can guide family counselling and help determine eligibility for targeted treatments.

• Electromyography (EMG) and nerve conduction studies: Help determine whether weakness originates from the muscle itself or from a nerve-related condition.

• Muscle biopsy: It can be used in cases where the diagnosis is still uncertain or when tissue analysis is required to confirm the dystrophy patterns.

• Heart and lung tests: ECG and other cardiac tests look for rhythm problems or cardiomyopathy, while breathing tests check for weakness in the respiratory muscles. These assessments are important during the initial diagnosis and regular follow-up.

How is Muscular Dystrophy Treated Based on Severity?

Muscular dystrophy treatment is adjusted as the condition progresses and new complications develop. The table below outlines common approaches at different stages:

Most patients need a combination of these approaches, with the plan evolving as muscle dysfunction progresses.

Types of Muscular Dystrophy and Their Treatment

Muscular dystrophy includes several clinically distinct types, each differing in affected muscles, age of onset and complications. Treatment is therefore individualised.

The specific type guides which specialists are involved and how closely the heart, lungs and swallowing muscles need to be monitored.

Physiotherapy, Rehabilitation and Assistive Treatments for Muscular Dystrophy

Physiotherapy and rehabilitation form the core of muscular dystrophy treatment because they help maintain muscle strength, flexibility and function for as long as possible.

Other Treatments for Muscular Dystrophy

Muscular dystrophy may require additional specialist care beyond physiotherapy and rehabilitation, depending on the organs affected.

• Cardiac care: Monitoring, medicines such as ACE inhibitors or beta blockers, and device-based treatment such as pacemaker support may be needed when muscular dystrophy affects the heart muscle or causes rhythm problems.

• Speech and swallowing therapy: May be recommended when facial, throat or swallowing muscles are affected. This helps with communication, safer swallowing and nutrition planning.

• Surgery: May be considered for complications such as scoliosis, leg contractures, cataracts in some types, or selected heart-related problems. Surgery decisions require careful pre-operative assessment because breathing, heart and mobility limitations can affect anaesthesia and recovery.

• Nutrition support: A personalised diet plan may help if steroid-related weight gain, swallowing problems, poor appetite, or reduced mobility affects overall health. Both being underweight and carrying excess weight can make movement more difficult and increase day-to-day care needs.

Note: Cardiac, respiratory and surgical interventions require specialist assessment and ongoing monitoring under a multidisciplinary team.

Oral Medications for Muscular Dystrophy Treatment

Medicines used in muscular dystrophy treatment are prescribed based on the type, stage and complications involved.

• Corticosteroids: May be prescribed in Duchenne muscular dystrophy to help maintain muscle strength and slow progression. Examples include prednisone and deflazacort. Benefits must be balanced against side effects such as weight gain, bone thinning, behaviour changes and infection risk.

• Heart medicines: ACE inhibitors and beta blockers may help manage heart problems, while diuretics may be used for people with signs of heart failure.

• Mutation-targeted exon-skipping medicines: Specialist treatments for selected Duchenne muscular dystrophy patients with specific DMD gene mutations. Examples with US FDA accelerated approval include eteplirsen, golodirsen, viltolarsen and casimersen. These apply only to a minority of mutation profiles and require genetic confirmation.

• Newer disease-modifying medicines: Vamorolone, a corticosteroid-like anti-inflammatory medicine, and givinostat, a histone deacetylase inhibitor, have received US FDA approval for eligible Duchenne muscular dystrophy patients. These are specialist-led options and may not be suitable for every patient.

Note: These medicines should be taken only as prescribed by a doctor.

Ayurvedic and Alternative Treatments for Muscular Dystrophy

Listed below are some Ayurvedic treatment options discussed for managing muscular dystrophy:

• Abhyanga: Therapeutic massage using medicated oils may be used as part of the Ayurvedic management approach.

• Swedana: Sudation or fomentation therapy may be used to support the management of muscle stiffness and weakness.

• Basti: Medicated enema therapy is described as part of the Ayurvedic treatment approach for conditions involving Vata imbalance.

• Shashtika shali pinda sweda: A specialised therapy using medicated rice boluses may be used as part of Ayurvedic management to support muscle strength and nourishment.

• Rasayana therapy: Rejuvenation therapies and Ayurvedic formulations may be used to support overall strength and muscle function.

Note: Muscular dystrophy requires specialist medical care. Ayurvedic or alternative therapies should not replace standard treatment and should only be used under appropriate medical supervision.

Home Care for Managing Muscular Dystrophy

Muscular dystrophy home care plays an important role in maintaining function and preventing complications between clinic visits.

• Follow the physiotherapist's home exercise plan: Gentle stretching, range-of-motion activity and low-intensity movement suited to the patient's strength help preserve function. Complete bed rest or inactivity can worsen weakness.

• Make the home safer: Leave enough room for mobility aids, ensure easy access to bathing and toileting, and use braces or wheelchairs when needed to make everyday activities easier and help the person stay as independent as possible.

• Follow breathing and chest-care plans: If prescribed, continue airway clearance and breathing exercises at home. Patients with respiratory muscle weakness should seek prompt medical review during cough, fever or chest infection.

• Watch for warning signs: Symptoms such as recent swallowing problems, choking, unexplained weight changes, chest infections, fatigue, reduced mobility, pain, palpitations or shortness of breath may indicate complications that require changes to treatment.

Latest Treatment for Muscular Dystrophy in India

Recent advances in the treatment of muscular dystrophy (particularly DMD) have focused on therapies that target the underlying genetic cause. These include exon-skipping medicines for specific gene mutations, newer medicines such as vamorolone and givinostat, and gene replacement therapy designed to deliver a functional form of dystrophin. These treatments are intended for selected patients and depend on the type of muscular dystrophy and the individual's genetic profile.

New treatment approaches, including gene-editing technologies (e.g., CRISPR/Cas9) that may help address disease-causing genetic changes, are being investigated. Stem cell-based and other regenerative therapies are also under study. However, further research is needed to better understand their long-term safety and effectiveness.

How Long Does Muscular Dystrophy Treatment Take?

Muscular dystrophy treatment is typically long-term, with different components running in parallel over months or years.

Because muscular dystrophy is a progressive condition, most patients require continuous, evolving care rather than a fixed treatment course.

Muscular Dystrophy Treatment Side Effects

Muscular dystrophy treatments can carry side effects that require specialist monitoring and management.

• Corticosteroids: Long-term use may cause weight gain, mood or behaviour changes, high blood pressure, delayed growth, cataracts, increased infection risk and bone thinning.

• Heart medicines: ACE inhibitors, beta blockers and diuretics can cause low blood pressure, dizziness, heart rate changes or electrolyte imbalances.

• Assistive devices and braces: Can cause discomfort, skin pressure or poor fit if not reviewed as the patient grows or weakness changes. Regular orthotic review helps reduce these issues.

• Surgery and anaesthesia: Heart, breathing and mobility limitations can increase operative risk and affect rehabilitation. A thorough pre-operative cardiac, respiratory and nutritional assessment is important.

Lifestyle Changes for Managing Muscular Dystrophy

Lifestyle adjustments can help people with muscular dystrophy maintain quality of life and slow functional decline.

• Maintain safe physical activity: Gentle, submaximal aerobic activity such as assisted swimming or cycling may be helpful. High-resistance and eccentric exercises should be avoided because overexertion may increase muscle injury risk.

• Conserve energy wisely: Pacing, rest breaks, adaptive seating, mobility aids and school or workplace adjustments recommended by occupational therapists help patients continue daily activities without excessive fatigue.

• Support healthy nutrition: Focus on maintaining healthy weight, bone health and swallowing safety. This is especially important for patients on steroids, those with limited mobility and those with chewing or swallowing difficulty.

• Plan vaccinations and infection prevention: Patients with respiratory muscle weakness or steroid exposure are more vulnerable to chest infections. Staying up to date with vaccinations and taking infection precautions can help prevent respiratory complications.

Factors that Can Worsen Muscular Dystrophy Symptoms

Several factors can worsen muscle weakness or increase the risk of complications in muscular dystrophy.

• Complete inactivity or prolonged bed rest: Can worsen weakness and reduce function further. Movement should be maintained within safe limits advised by the care team.

• Overexertion and high-resistance exercise: Damaged muscles may be more vulnerable to injury in muscular dystrophy, particularly in the Duchenne type. Activity should be gentle, monitored and stopped if fatigue, pain or breathlessness increases.

• Chest infections: Can worsen breathing significantly in patients with respiratory muscle weakness. New cough, fever, breathlessness, poor cough strength or unusual sleepiness should be treated as urgent.

• Untreated heart complications: Undetected cardiomyopathy or rhythm problems can worsen fatigue, breathlessness and exercise tolerance. Regular cardiac monitoring helps catch these complications early.

Muscular Dystrophy Treatment Cost

The cost of treating muscular dystrophy in India depends on the type of muscular dystrophy, severity of symptoms, treatment requirements, and need for long-term care. The annual cost of Duchenne muscular dystrophy is around ₹2.68 lakh per patient, including medical care, investigations, hospitalisation, medicines, equipment, and other related expenses.

Other treatment expenses include diagnostic tests such as a Duchenne/Becker muscular dystrophy gene mutation test (around ₹7,980), a muscular dystrophy gene panel (starting at ₹24,000), and electromyography or EMG (starting at around ₹4,950). Costs can increase further with physiotherapy, mobility aids, cardiac and respiratory care, hospitalisation, and long-term supportive treatment.

Does Health Insurance Cover Muscular Dystrophy Treatment in India?

Yes. Muscular dystrophy treatment that requires hospitalisation or day care procedures is typically covered under health insurance. OPD expenses, including consultations and physiotherapy, are covered if the policy includes OPD benefits. If muscular dystrophy was diagnosed or symptomatic before buying the policy, it may be treated as a pre-existing disease. IRDAI states that disclosed pre-existing conditions can be covered after the policy's waiting period, up to a maximum of 48 months. Check your policy wording for specific terms, sub-limits and exclusions.